636 related articles for article (PubMed ID: 9390594)
1. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
2. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
3. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
Naguib M; Riad W
Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
Smith CE; Donati F; Bevan DR
Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
[TBL] [Abstract][Full Text] [Related]
10. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
11. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M
J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
[TBL] [Abstract][Full Text] [Related]
13. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.
Salib Y; Frossard J; Plaud B; Debaene B; Meistelman C; Donati F
Can J Anaesth; 1994 Oct; 41(10):908-12. PubMed ID: 8001209
[TBL] [Abstract][Full Text] [Related]
15. Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients.
Keleş GT; Yentür A; Cavuş Z; Sakarya M
Eur J Anaesthesiol; 2004 Nov; 21(11):877-81. PubMed ID: 15717704
[TBL] [Abstract][Full Text] [Related]
16. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
17. [Priming technique with cisatracurium Onset time at the laryngeal muscles].
Schmidt J; Albrecht S; Petterich N; Fechner J; Klein P; Irouschek A
Anaesthesist; 2007 Oct; 56(10):992-1000. PubMed ID: 17598079
[TBL] [Abstract][Full Text] [Related]
18. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
